Sa A. Wang – författare

Part of the popular Foundations in Diagnostic Pathology Series, Hematopathology, Fourth Edition, is a practical and affordable resource that is ideal for study and review as well as everyday clinical practice. With its highly templated format, clearly written text, and concise summary tables, this user-friendly reference helps both trainees and practicing pathologists form accurate diagnoses, avoid pitfalls, and confidently sign out pathology reports on these often difficult and challenging cases.

Flow cytometry plays a critical role in the diagnosis of hematopoietic neoplasms. Understanding the key immunophenotypic features of each entity is essential for accurate diagnosis. Filling a crucial gap in current literature, this is a comprehensive reference text that systematically details these immunophenotypic profiles. Grounded in real-world experience, this practice-driven resource offers expert guidance on the use of flow cytometry in the diagnosis and classification of hematolymphoid neoplasms. Covering major disease categories, technical insights, and emerging therapies like CAR T-cells, readers will gain a solid foundation for identifying deviations seen in hematologic malignancies, thereby enhancing diagnostic accuracy. Each chapter concludes with key points and diagnostic pitfalls for efficient comprehension and retention. This is an essential tool for pathologists, hematologists, trainees, and laboratory professionals seeking clarity and confidence in diagnosis.

This book focuses on hematopoietic and lymphoid neoplasms that initially present as peripheral blood abnormalities, with either cytopenias or elevated peripheral blood counts, as well as non-neoplastic conditions that may raise concern for a hematologic malignancy. The scope of the book includes myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPN), as well as lymphomas and lymphoid leukemias that typically present initially with peripheral blood abnormalities.  Within each category, a comprehensive list of differential diagnoses is discussed. For each disease entity, the reader is updated with new molecular genetic data, biomarkers, and recent applications of immunophenotyping, and how to incorporate the new information in disease diagnosis and classifications is illustrated, including the use of diagnostic algorithms where appropriate. The book employs the revised WHO Classification of Hematopoietic Neoplasmsfor all disease entities.   Diagnosis of Blood and Bone Marrow Disorders will serve as a very useful resource for pathologists, pathologists in training, hematologists and medical technologists who are involved in the clinical work-up of patients with bone marrow and blood neoplasms.  It will provide a practical and concise yet comprehensive review.

This book focuses on hematopoietic and lymphoid neoplasms that initially present as peripheral blood abnormalities, with either cytopenias or elevated peripheral blood counts, as well as non-neoplastic conditions that may raise concern for a hematologic malignancy. The scope of the book includes myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPN), as well as lymphomas and lymphoid leukemias that typically present initially with peripheral blood abnormalities.  Within each category, a comprehensive list of differential diagnoses is discussed. For each disease entity, the reader is updated with new molecular genetic data, biomarkers, and recent applications of immunophenotyping, and how to incorporate the new information in disease diagnosis and classifications is illustrated, including the use of diagnostic algorithms where appropriate. The book employs the revised WHO Classification of Hematopoietic Neoplasmsfor all disease entities.   Diagnosis of Blood and Bone Marrow Disorders will serve as a very useful resource for pathologists, pathologists in training, hematologists and medical technologists who are involved in the clinical work-up of patients with bone marrow and blood neoplasms.  It will provide a practical and concise yet comprehensive review.